New and Delayed Artifactual Hypoglycemia Following Septic Shock in Two Scleroderma Patients
- PMID: 37583724
- PMCID: PMC10423685
- DOI: 10.7759/cureus.41900
New and Delayed Artifactual Hypoglycemia Following Septic Shock in Two Scleroderma Patients
Abstract
The term artifactual hypoglycemia refers to a discrepancy between plasma glucose levels and what is noted on fingerstick glucose checks. In this report, we discuss the cases of two patients with scleroderma and Raynaud's phenomenon who developed artifactual hypoglycemia while recovering from critical illness. In both cases, validation by earlobe measurements helped avoid further escalation of care and potential patient safety issues. There have been previous reports of artifactual hypoglycemia in this patient population, but the unique timing of symptom onset in these two patients provides a more nuanced understanding of the pathophysiology of this phenomenon.
Keywords: capillary blood glucose; factitious hypoglycemia; fingerstick; patient health safety; systemic scleroderma.
Copyright © 2023, Guzner et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Artifactual hypoglycemia in a patient with systemic sclerosis. Mertens J, Haddad M. Acta Clin Belg. 2022;77:400–405. - PubMed
-
- Alternative site testing at the earlobe tip: reliability of glucose measurements and pain perception. Toledo FG, Taylor A. Diabetes Care. 2004;27:616–617. - PubMed
-
- Importance of alternative-site blood glucose testing in the diagnosis of artifactual hypoglycaemia in systemic scleroderma. Dubourdieu V, Mosbah H, Amouyal C, Hartemann A, Andreelli F. Diabetes Metab. 2017;43:490–491. - PubMed
-
- Effects of arterial versus venous sampling on analysis of glucose kinetics in man. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M. J Appl Physiol. 1976;41:565–573. - PubMed
Publication types
LinkOut - more resources
Full Text Sources